Molecular Imaging 2017

Identification of a MRI perfusion biomarker to anticipate progression of glioblastoma after radio-chemotherapy

• 25 patients of spectro glio trial , follow up > 6 months • Analysis of 11 perfusion biomarkers

2 months , 4 months and 6 months before the last MR acquisition with confirmed disease status were analyzed, with a total of 100 scans analyzed

Khalifa et al, Eur J Radiology 2016